Lamotrigine add-on therapy in focal epilepsy: Electroencephalographic and neuropsychological evaluation

被引:0
作者
Marciani, MG
Stanzione, P
Mattia, D
Spanedda, F
Bassetti, MA
Maschio, M
Bernardi, G
机构
[1] Univ Roma Tor Vergata, Dip Sanita Pubbl, Neurol Clin, I-00173 Rome, Italy
[2] IRCCS, S Lucia Rome, Italy
关键词
lamotrigine; epilepsy; computerized EEG; mental activity;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effect of lamotrigine (LTG) as add-on therapy on electroencephalogram (EEG) background activity was studied in 11 patients with refractory partial seizures with or without secondary generalization. The computerized EEG study was performed at rest with eyes closed (EC), during blocking reaction (BR), fixation (FIX), and mental arithmetic (MA) tasks. EEG spectral values were analyzed statistically using three-way ANOVA. The neuropsychological evaluation included a battery of six tests. Epileptic patients before LTG therapy, compared with control subjects, displayed at rest condition EEG changes consisting of higher delta and theta relative power coupled with lower alpha and beta power. During performance of attentive (BR) and cognitive (FIX) tasks, a decrease in alpha reactivity associated with a decrease of beta1 and beta2 power was found. The addition of LTG to previous therapy induced changes, although subtle, consisting of an increase in both alpha reactivity and beta power to attentive task. Neuropsychological evaluation did not evidence any impairment of cognitive functions. During LTG therapy, a decrease in seizure frequency occurred in 9 of the 11 patients whereas no changes were observed in the remaining 2. On the basis of these neurophysiologic and neuropsychological findings, LTG as add-on therapy does not seem to produce adverse side effects on mental activity, moreover, EEG data indicate a slight improvement in attentional processes.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 50 条
[21]   Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy [J].
Ben-Menachem, E ;
Edrich, P ;
Van Vleymen, B ;
Sander, JWA ;
Schmidt, B .
EPILEPSY RESEARCH, 2003, 53 (1-2) :57-64
[22]   LONG-TERM OBSERVATIONS ON THE CLINICAL USE OF LAMOTRIGINE AS ADD-ON DRUG IN PATIENTS WITH EPILEPSY [J].
COCITO, L ;
MAFFINI, M ;
LOEB, C .
EPILEPSY RESEARCH, 1994, 19 (02) :123-127
[23]   LAMOTRIGINE AS AN ADD-ON DRUG IN TYPICAL ABSENCE SEIZURES [J].
FERRIE, CD ;
ROBINSON, RO ;
KNOTT, C ;
PANAYIOTOPOULOS, CP .
ACTA NEUROLOGICA SCANDINAVICA, 1995, 91 (03) :200-202
[24]   Rufinamide as add-on treatment in focal epilepsy. Preliminary analysis of 31 patients [J].
Boes, M. ;
Bauer, J. .
ZEITSCHRIFT FUR EPILEPTOLOGIE, 2010, 23 (03) :194-197
[25]   Brivaracetam use in clinical practice: a Delphi consensus on its role as first add-on therapy in focal epilepsy and beyond [J].
Lattanzi, Simona ;
Chiesa, Valentina ;
Di Gennaro, Giancarlo ;
Ferlazzo, Edoardo ;
Labate, Angelo ;
La Neve, Angela ;
Meletti, Stefano ;
Di Bonaventura, Carlo .
NEUROLOGICAL SCIENCES, 2024, 45 (11) :5557-5557
[26]   Efficacy of Clobazam as Add-on Therapy for Refractory Epilepsy: Experience at a US Epilepsy Center [J].
Montenegro, Maria A. ;
Arif, Hiba ;
Nahm, Edmund A. ;
Resor, Stanley R., Jr. ;
Hirsch, Lawrence J. .
CLINICAL NEUROPHARMACOLOGY, 2008, 31 (06) :333-338
[27]   Open study of pranlukast add-on therapy in intractable partial epilepsy [J].
Takahashi, Yukitoshi ;
Imai, Katsumi ;
Ikeda, Hitoshi ;
Kubota, Yuko ;
Yamazaki, Etsuko ;
Susa, Fuminobu .
BRAIN & DEVELOPMENT, 2013, 35 (03) :236-244
[28]   Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy [J].
Tanaka, Shigeya ;
Tanaka, Tatsuya .
EPILEPTIC DISORDERS, 2013, 15 (02) :132-141
[29]   Clinical trial of pregabalin as an add-on therapy in children with refractory epilepsy [J].
Bali, M. K. Bakhshandeh ;
Ashrafi, Mahmoud R. ;
Otaghsara, Seyedeh Mohadeseh Taheri ;
Nasehi, Mohammad M. ;
Azargashb, Eznollah ;
Karimzadeh, Parvaneh ;
Ghofrani, Mohammad .
JOURNAL OF PEDIATRIC EPILEPSY, 2013, 2 (02) :125-129
[30]   Behavioral intervention as an add-on therapy in epilepsy: Designing a clinical trial [J].
Polak, Emily L. ;
Privitera, Michael D. ;
Lipton, Richard B. ;
Haut, Sheryl R. .
EPILEPSY & BEHAVIOR, 2012, 25 (04) :505-510